Terence Flotte
Affiliations: | University of Florida, Gainesville, Gainesville, FL, United States |
Area:
Genetics, Microbiology BiologyGoogle:
"Terence Flotte"Children
Sign in to add traineeRenius Owen | grad student | 2001 | UF Gainesville |
Jeffrey R. Sirninger | grad student | 2003 | UF Gainesville |
Christian Muller | grad student | 2006 | UF Gainesville |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Arjomandnejad M, Dasgupta I, Flotte TR, et al. (2023) Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. 1-19 |
Tang Q, Keeler AM, Zhang S, et al. (2020) Two-Plasmid Packaging System for Recombinant Adeno-Associated Virus. Bioresearch Open Access. 9: 219-228 |
Flotte TR. (2018) Airway Basal Cells Are the Key for Cystic Fibrosis Gene Therapy. Human Gene Therapy. 29: 641-642 |
Wang D, Li S, Gessler DJ, et al. (2018) A Rationally Engineered Capsid Variant of AAV9 for Systemic CNS-Directed and Peripheral Tissue-Detargeted Gene Delivery in Neonates. Molecular Therapy. Methods & Clinical Development. 9: 234-246 |
Borel F, Tang Q, Gernoux G, et al. (2017) Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency. Molecular Therapy : the Journal of the American Society of Gene Therapy |
Flotte TR. (2017) Adeno-Associated Virus-Human Bocavirus 1 Chimeric Vectors: Ferreting Out Their Role in Airway Gene Therapy. Human Gene Therapy. 28: 611 |
Loring HS, ElMallah MK, Flotte TR. (2016) Development of RAAV2-CFTR: History of the First RAAV Vector Product to be Used in Humans. Human Gene Therapy Methods |
Gruntman AM, Flotte TR. (2015) Progress with Recombinant Adeno-Associated Virus Vectors for Gene Therapy of Alpha-1 Antitrypsin Deficiency. Human Gene Therapy Methods. 26: 77-81 |
Borel F, Choudhury S, Aslanidi G, et al. (2015) 183. Developing Strategies To Improve the Current Clinical Vector AAV1-CB-AAT for Alpha-One Antitrypsin Deficiency Molecular Therapy. 23: S73 |
Flotte TR. (2013) Birth of a new therapeutic platform: 47 years of adeno-associated virus biology from virus discovery to licensed gene therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1976-81 |